The lipidated peptidomimetic Lau-[(S)-Aoc]-(Lys-βNphe)6-NH2 is a novel formyl peptide receptor 2 agonist that activates both human and mouse neutrophil NADPH-oxidase

Neutrophils expressing formyl peptide receptor 2 (FPR2) play key roles in host defense, immune regulation, and in resolution of inflammation. Consequently, the search for FPR2-specific modulators has attracted much attention due to its therapeutic potential. Earlier described agonists for this recep...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 2016, Vol.291, p.19888
Main Authors: Holdfeldt, André, Skovbakke, Sarah Line, Winther, Malene, Gabl, Michael, Nielsen, Christina, Perez-Gassol, Iris, Larsen, Camilla Josephine, Wang, Ji Ming, Karlsson, Anna, Dahlgren, Claes, Forsman, Huamei, Franzyk, Henrik
Format: Article
Language:English
Subjects:
Basic Medicine
Clinical Medicine
G-protein-coupled receptor (GPCR)
inflammation
Klinisk medicin
Medicinska grundvetenskaper
NADPH oxidase
neutrophil
receptor structure-function
structure-function
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Neutrophils expressing formyl peptide receptor 2 (FPR2) play key roles in host defense, immune regulation, and in resolution of inflammation. Consequently, the search for FPR2-specific modulators has attracted much attention due to its therapeutic potential. Earlier described agonists for this receptor display potent activity for the human receptor (FPR2) but low activity for the mouse receptor orthologue (Fpr2), rendering them inapplicable in murine models of human disease. Here we describe a novel FPR2 agonist, the proteolytically stable α-peptide/β-peptoid hybrid Lau-[(S)-Aoc]-(Lys-βNphe)6-NH2 (F2M2), showing comparable potency in activating human and mouse neutrophils by inducing a rise in intracellular calcium and assembly of the superoxide-generating NADPH-oxidase. The FPR2/Fpr2 agonist contains a headgroup of 2-aminooctanoic acid (Aoc) residue acylated with lauric acid (C12 fatty acid), which is linked to a peptide/peptoid repeat (Lys-βNphe)6-NH2). Both the fatty acid moiety and the (S)-Aoc residue were required for FPR2/Fpr2 activation. This type of proteolytically stable FPR2-specific peptidomimetics may serve as valuable tools for future analysis of FPR2 signaling as well as for development of prophylactic immunomodulatory therapy. This novel class of cross-species FPR2/Fpr2 agonists should enable translation of results obtained with mouse neutrophils (and disease models) into enhanced understanding of human inflammatory and immune diseases.
ISSN:1083-351X
DOI:10.1074/jbc.M116.736850